F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
36.68
-0.35 (-0.95%)
Jan 8, 2026, 4:00 PM EST - Market closed
LFSC Holdings Information
LFSC is an equity ETF with a total of 40 individual holdings. The top holdings are Cogent Biosciences stock at 8.11%, LivaNova at 6.69%, Guardant Health at 5.67%, Wave Life Sciences at 5.65%, and Travere Therapeutics at 5.56%.
Total Holdings
40
Top 10 Percentage
51.69%
Asset Class
Equity
ETF Category
Health
Assets
91.93M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | COGT | Cogent Biosciences, Inc. | 8.11% |
| 2 | LIVN | LivaNova PLC | 6.69% |
| 3 | GH | Guardant Health, Inc. | 5.67% |
| 4 | WVE | Wave Life Sciences Ltd. | 5.65% |
| 5 | TVTX | Travere Therapeutics, Inc. | 5.56% |
| 6 | TMDX | TransMedics Group, Inc. | 4.81% |
| 7 | MIRM | Mirum Pharmaceuticals, Inc. | 4.01% |
| 8 | UTHR | United Therapeutics Corporation | 3.78% |
| 9 | SVRA | Savara Inc. | 3.72% |
| 10 | BBIO | BridgeBio Pharma, Inc. | 3.69% |
| 11 | KALV | KalVista Pharmaceuticals, Inc. | 3.68% |
| 12 | ICUI | ICU Medical, Inc. | 3.28% |
| 13 | MDGL | Madrigal Pharmaceuticals, Inc. | 3.17% |
| 14 | SYRE | Spyre Therapeutics, Inc. | 3.11% |
| 15 | ACAD | ACADIA Pharmaceuticals Inc. | 2.68% |
| 16 | TRVI | Trevi Therapeutics, Inc. | 2.62% |
| 17 | CORT | Corcept Therapeutics Incorporated | 2.33% |
| 18 | COLL | Collegium Pharmaceutical, Inc. | 2.29% |
| 19 | AXSM | Axsome Therapeutics, Inc. | 2.26% |
| 20 | NKTR | Nektar Therapeutics | 2.25% |
| 21 | ITGR | Integer Holdings Corporation | 2.04% |
| 22 | INSM | Insmed Incorporated | 1.99% |
| 23 | CBLL | CeriBell, Inc. | 1.98% |
| 24 | ATEC | Alphatec Holdings, Inc. | 1.74% |
| 25 | BLLN | BillionToOne, Inc. | 1.65% |
As of Jan 6, 2026